Cargando…
Is Body Mass Index (BMI) Associated with Risk and Outcomes of COVID-19 in Iranian Multiple Sclerosis Patients?
INTRODUCTION: It seems that Multiple sclerosis (MS) patients are at the higher risk for COVID-19 implications due to the use of immunomodulatory or immunosuppressive treatments. Obesity as a risk factor may lead to more adverse consequences . Relationship between obesity and COVID-19 risk and outcom...
Autores principales: | Rezaeimanesh, Nasim, Abbasi, Naghmeh, Sahraian, Mohammad Ali, Azimi, Amirreza, Moghadasi, Abdorreza Naser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065168/ http://dx.doi.org/10.1016/j.msard.2022.104290 |
Ejemplares similares
-
The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023) -
Use of Social Media Tools during COVID-19 Pandemic Among MS Fellowships and Patients
por: Mokhberdezfuli, Mahdieh, et al.
Publicado: (2023) -
Role of Type 1 Interferons therapy on Adverse Clinical Outcomes on COVID-19 in Hospitalized Multiple Sclerosis Patients
por: Maghbooli, Zhila, et al.
Publicado: (2023) -
Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A MENACTRIMS Registry Based Study
por: Zeineddine, Maya, et al.
Publicado: (2023) -
Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-Cov-2 in Patients with Multiple Sclerosis on B-Cell Depleters
por: Conte, William L., et al.
Publicado: (2023)